A new study lacked significant results, but when combined with additional studies, the prevention of cardiovascular events ...
Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron ...
Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...
News Medical on MSN2d
Heart failure patients benefit from dapagliflozin after TAVR procedurePatients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...
In response to this urgent issue, UCLA Health has established the South Asian Heart Program, a pioneering initiative aimed at ...
A new study that looked at how liberal vs. restrictive fluid restriction impacts health status for patients with chronic ...
Among patients with heart failure with mildly reduced ejection fraction/heart failure with preserved ejection fraction in the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in ...
News Medical on MSN1d
Intravenous iron shows promise for heart failure with reduced ejection fractionAmong iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback